Skip to content

CHINA PHARMA HOLDINGS, INC.: 10-Q filed 2016-08-11

What CHINA PHARMA HOLDINGS, INC. reported in its quarterly report filed 2016-08-11 (fiscal Q2 2016): 36 published measures, 101 facts as tagged in accession 0001010549-16-000678.

This filing

Form
10-Q (quarterly report)
Filed
2016-08-11
Fiscal period
fiscal Q2 2016
Accession
0001010549-16-000678 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CHINA PHARMA HOLDINGS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2016-06-3091,977,253USD
At 2015-12-3197,222,233USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2016-06-3025,016,011USD
At 2015-12-3124,581,084USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2016-06-3066,961,242USD
At 2015-12-3172,641,149USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2016-04-01 to 2016-06-30-2,453,802USD91
2016-01-01 to 2016-06-30-4,006,698USD182
2015-04-01 to 2015-06-301,127,322USD91
2015-01-01 to 2015-06-30-6,846,621USD181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2016-01-01 to 2016-06-30554,879USD182
2015-01-01 to 2015-06-30-515,711USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2016-01-01 to 2016-06-3066,213USD182
2015-01-01 to 2015-06-30264,869USD181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2016-04-01 to 2016-06-303,542,230USD91
2016-01-01 to 2016-06-307,182,724USD182
2015-04-01 to 2015-06-305,674,175USD91
2015-01-01 to 2015-06-3011,369,105USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2016-01-01 to 2016-06-30-306,028USD182
2015-01-01 to 2015-06-300USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2016-01-01 to 2016-06-30-66,213USD182
2015-01-01 to 2015-06-30-264,869USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2016-06-3029,933,300USD
At 2015-12-3133,939,998USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2016-04-01 to 2016-06-3043,579,557shares91
2016-01-01 to 2016-06-3043,579,557shares182
2015-04-01 to 2015-06-3043,579,557shares91
2015-01-01 to 2015-06-3043,579,557shares181

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2016-04-01 to 2016-06-3043,579,557shares91
2016-01-01 to 2016-06-3043,579,557shares182
2015-04-01 to 2015-06-3043,579,557shares91
2015-01-01 to 2015-06-3043,579,557shares181

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2016-04-01 to 2016-06-30-0.06USD/shares91
2016-01-01 to 2016-06-30-0.09USD/shares182
2015-04-01 to 2015-06-300.03USD/shares91
2015-01-01 to 2015-06-30-0.16USD/shares181

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2016-04-01 to 2016-06-30-0.06USD/shares91
2016-01-01 to 2016-06-30-0.09USD/shares182
2015-04-01 to 2015-06-300.03USD/shares91
2015-01-01 to 2015-06-30-0.16USD/shares181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2016-06-3027,214,609USD
At 2015-12-3129,393,257USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2016-04-01 to 2016-06-30-2,221,626USD91
2016-01-01 to 2016-06-30-3,542,977USD182
2015-04-01 to 2015-06-301,438,950USD91
2015-01-01 to 2015-06-30-6,228,789USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2016-06-3023,816,977USD
At 2015-12-3124,957,252USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2016-04-01 to 2016-06-30243,883USD91
2016-01-01 to 2016-06-30486,192USD182
2015-04-01 to 2015-06-30322,422USD91
2015-01-01 to 2015-06-30636,197USD181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2016-06-3014,100,555USD
At 2015-12-3112,791,125USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2016-04-01 to 2016-06-303,052,395USD91
2016-01-01 to 2016-06-305,014,565USD182
2015-04-01 to 2015-06-30-1,494,777USD91
2015-01-01 to 2015-06-307,232,089USD181

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2016-06-308,938,484USD
At 2015-12-319,662,750USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2016-04-01 to 2016-06-30482,097USD91
2016-01-01 to 2016-06-301,122,916USD182
2015-04-01 to 2015-06-30-55,827USD91
2015-01-01 to 2015-06-301,003,300USD181

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2016-04-01 to 2016-06-302,868,031USD91
2016-01-01 to 2016-06-305,939,492USD182
2015-04-01 to 2015-06-304,511,951USD91
2015-01-01 to 2015-06-308,946,657USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2016-04-01 to 2016-06-3096,661USD91
2016-01-01 to 2016-06-30190,094USD182
2015-04-01 to 2015-06-30174,850USD91
2015-01-01 to 2015-06-30335,678USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2016-06-3043,579,557shares
At 2015-12-3143,579,557shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2016-06-3023,590,204USD
At 2015-12-3123,590,204USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2016-06-3010,774,784USD
At 2015-12-319,422,912USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2016-06-30689,961USD
At 2015-12-31841,075USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2016-06-3039,933USD
At 2015-12-31143,409USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2016-04-01 to 2016-06-30-2,432,386USD91
2016-01-01 to 2016-06-30-3,962,454USD182
2015-04-01 to 2015-06-301,146,750USD91
2015-01-01 to 2015-06-30-6,807,909USD181

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2016-01-01 to 2016-06-30-4,006,698USD182
2015-01-01 to 2015-06-30-6,846,621USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2016-04-01 to 2016-06-30780,953USD91
2016-01-01 to 2016-06-301,099,883USD182
2015-04-01 to 2015-06-30459,026USD91
2015-01-01 to 2015-06-30931,455USD181

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2016-01-01 to 2016-06-301,728,273USD182
2015-01-01 to 2015-06-301,884,749USD181

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

PeriodValueUnitDays
2016-04-01 to 2016-06-300USD91

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2016-04-01 to 2016-06-3021,416USD91
2016-01-01 to 2016-06-3044,244USD182
2015-04-01 to 2015-06-3019,428USD91
2015-01-01 to 2015-06-3038,712USD181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2016-01-01 to 2016-06-302,767,597USD182
2015-01-01 to 2015-06-302,508,519USD181

Inspect the source

Entity
CHINA PHARMA HOLDINGS, INC. / CIK 0001106644
Captured
2026-09-20T05:23:28.377Z
SEC response SHA-256
ad45dffd15d0f5a098ab8b6912816a8b1b845b1d791781ea412833d3178873c0

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001106644.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))